A New Hypoxia-Related Prognostic Risk Score (HPRS) Model Was Developed to Indicate Prognosis and Response to Immunotherapy for Lung Adenocarcinoma

Figure 4

The relation between genetic alterations and HPRS in LUAD. (a): The Pearson correlation between HPRS and aneuploidy score, homologous recombination defects, fraction altered, number of segments, and tumor mutation burden, respectively. (b): Differences in aneuploidy score, homologous recombination defects, fraction altered, number of segments, and tumor mutation burden between the two HPRS groups. (c): Comparison of mutation spectrum between high and low HPRS groups. , .

(a)

(b)

(c)